Vivos Therapeutics, Inc. · NASDAQ:VVOS
V-Co Investors 3 LLC bought 1,353,625 Vivos Therapeutics, Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, V-Co Investors 3 LLC (10% owner) bought 1,353,625 Vivos Therapeutics, Inc. shares at US$1.34 for US$1.81M, leaving 1,353,625 shares. Filed Apr 2, 2026 (Form 4).
- Bought
- 1,353,625 shares
- Price
- US$1.34
- Value
- US$1.81M
- Holding after
- 1,353,625 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Buy | 1,044,777 | US$1.34 | 1,044,777 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 308,848 | US$1.34 | 1,353,625 | Indirect |
Source
Related
- Vivos Therapeutics, Inc.
- V-Co Investors 3 LLC
- Vivos Therapeutics, Inc. shareholders
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026